About DRUGSCAN
DRUGSCAN was founded in 1985 in Horsham, United States, and operates within the healthcare sector focused on toxicology. Services encompass testing for substance use disorders, workplace monitoring for professionals, and reference laboratory support. Confirmation testing is offered to hospitals and labs, alongside reports that assist in patient care and treatment planning. Operations emphasize efficiency in managing addiction and ensuring safer environments.
- Headquarter Horsham, United States
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Eureka Equity Partners
& 1 more
-
Employee Count
Not available
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of DRUGSCAN
Unlock access to complete
Funding Insights of DRUGSCAN
Detailed funding history for DRUGSCAN
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in DRUGSCAN
DRUGSCAN has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Eureka Equity Partners and ACM Global Central Laboratory.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A private equity firm focused on niche-market leaders is operated.
|
Locked | Locked | Locked | |
|
Provides bioanalytical, central lab, and toxicology services for global clinical trials.
|
Locked | Locked | Locked |
Investor details for DRUGSCAN
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by DRUGSCAN
Investment portfolio details for DRUGSCAN
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - DRUGSCAN
Detailed financials for DRUGSCAN
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Drugscan Comparisons
Peer comparison for DRUGSCAN
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of DRUGSCAN
Detailed competitors of DRUGSCAN
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Drugscan
Complete news archive for DRUGSCAN
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DRUGSCAN
DRUGSCAN was founded in 1985.
DRUGSCAN is headquartered in Horsham, United States. It is registered at Horsham, Pennsylvania, United States.
DRUGSCAN was founded in 1985 in Horsham, United States, and operates within the healthcare sector focused on toxicology. Services encompass testing for substance use disorders, workplace monitoring for professionals, and reference laboratory support. Confirmation testing is offered to hospitals and labs, alongside reports that assist in patient care and treatment planning. Operations emphasize efficiency in managing addiction and ensuring safer environments.
DRUGSCAN has 2 investors. Key investors include Eureka Equity Partners, and ACM Global Central Laboratory.